Skip to main content

Advertisement

Log in

Comparison of tumor regression rate of uterine cervical squamous cell carcinoma during external beam and intracavitary radiotherapy

  • Original Article
  • Published:
Radiation Medicine Aims and scope Submit manuscript

Abstract

Purpose

We compared the radioresponse of cervical carcinoma that was closely related to local disease control by the tumor regression rate (RR) during intracavitary radiotherapy (ICRT) and external beam radiotherapy (EBRT) on the presumption that ICRT has a stronger treatment impact than EBRT because of its specific dose distribution.

Materials and methods

A total of 37 patients were treated by EBRT at 45.0 Gy over 5 weeks, followed by high-dose-rate ICRT at 6.0 Gy per weekly insertion at point A three to five times and by boost EBRT. RR was defined as the slope (day−1) of the tumor-volume shrinkage curve fit to an exponential regression equation. Assuming that the tumors were ellipsoid, the tumor volume was estimated using magnetic resonance (MR) images obtained before treatment, after 45.0 Gy of EBRT, and after the third ICRT insertion. RRs were compared based on the radiotherapy method.

Results

RR ranged between −0.008 to 0.093 day−1 (median 0.021 day−1) during EBRT and −0.001 to 0.097 day−1 (median 0.018 day−1) during ICRT, showing no significant difference or correlation between treatments.

Conclusion

Contrary to expectations, RR did not directly relate to the impact of physical treatment. RR could be related to biological factors, such as the amount of tumor clearance and changes in tumor consistency during treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Perez CA, Grigsby PW, Chao KS, Mutch DG, Lockett MA. Tumor size, irradiation dose, and long-term outcome of carcinoma of uterine cervix. Int J Radiat Oncol Biol Phys 1998;41:307–317.

    PubMed  CAS  Google Scholar 

  2. Eifel PJ, Morris M, Wharton TJ, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994;29:9–16.

    PubMed  CAS  Google Scholar 

  3. Grossman I, Kurohara SS, Webster JH, Gorge FW 3rd. The prognostic significance of tumor response during radiotherapy in cervical carcinoma. Radiology 1973;107:411–415.

    PubMed  CAS  Google Scholar 

  4. Hardt N, van Nagell JR, Hanson M, Donaldson E, Yoneda J, Maruyama Y. Radiation-induced tumor regression as a prognostic factor in patients with cervical cancer. Cancer 1982;49:35–39.

    Article  PubMed  CAS  Google Scholar 

  5. Ohara K, Tsunoda H, Tanaka YO, Onishi K, Nemoto K, Hashimoto T, et al. Explanation for the failure of neoadjuvant chemotherapy to improve outcomes in radiotherapy for locally advanced uterine cervical cancer from the standpoint of tumor regression rate. Radiat Med 2007;25:53–59.

    Article  PubMed  CAS  Google Scholar 

  6. Hong JH, Chen MS, Lin FJ, Tang SG. Prognostic assessment of tumor regression after external irradiation for cervical cancer. Int J Radiat Oncol Biol Phys 1992;22:913–917.

    PubMed  CAS  Google Scholar 

  7. Saibishkumar EP, Patel FD, Sharma SC, Karunanidhi G, Ghoshal S, Kumar V, et al. Prognostic value of response to external radiation in stage IIIB cancer cervix in prediction clinical outcomes: a retrospective analysis of 556 patients from India. Radiother Oncol 2006:79;142–146.

    Article  PubMed  Google Scholar 

  8. Hricak H, Quivey J, Campos Z, Gildengorin V, Hindmarsh T, Bis KG, et al. Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993;27:791–801.

    PubMed  CAS  Google Scholar 

  9. Mayr NA, Yuh WT, Zheng J, Ehrhardt JC, Sorosky JI, Magnotta VA, et al. Tumor size evaluated by pelvic examination compared with 3-D MR quantitative analysis in prediction of outcome for cervical cancer. Int J Radiat Oncol Biol Phys 1997;39:395–404.

    PubMed  CAS  Google Scholar 

  10. Ohara K, Oki A, Tanaka YO, Onishi K, Fukumitsu N, Hashimoto T, et al. Early determination of uterine cervical squamous cell carcinoma radioresponse identifies high-and low-response tumors. Int J Radiat Oncol Biol Phys 2006;64:1179–1182.

    PubMed  Google Scholar 

  11. Ohara K, Tanaka YO, Tsunoda H, Sugahara S, Hashimoto T, Kagei K, et al. Nonoperative assessment of nodal status for locally advanced cervical squamous cell carcinoma treated by radiotherapy with regard to patterns of treatment failure. Int J Radiat Oncol Biol Phys 2003;55:354–361.

    PubMed  Google Scholar 

  12. Nag S, Erickson B, Thomadsen B, Orton C, Demanes JD, Petereit D. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2000;48:201–211.

    Article  PubMed  CAS  Google Scholar 

  13. Gong QY, Tan LT, Romaniuk CS, Jones B, Brunt JN, Roberts N. Determination of tumor regression rates during radiotherapy for cervical carcinoma by serial MRI: comparison of two measurement techniques and examination of intraobserver and interobserver variability. Br J Radiol 1999;72:62–72.

    PubMed  CAS  Google Scholar 

  14. Mayr NA, Yuh WT, Taoka T, Wang JZ, Wu DH, Montebello JF, et al. Serial therapy-induced changes in tumor shape in cervical cancer and their impact on assessing tumor volume and treatment response. AJR Am J Roentgenol 2006;187:65–72.

    Article  PubMed  Google Scholar 

  15. Ohara K, Hayakawa Y, Fuji H, Tatsuzaki H, Itai Y. Impact of biological clearance on tumor radioresponsiveness. Int J Radiat Oncol Biol Phys 1996;34:389–393.

    PubMed  CAS  Google Scholar 

  16. West CM, Davidson SE, Roberts SA, Hunter RD. The independence of intrinsic radiosensitivity as a prognostic factor for patient response to radiotherapy of carcinoma of the cervix. Br J Cancer 1997;79:1187–1190.

    Google Scholar 

  17. Lim K, Chan P, Dinniwell R, Fyles A, Haider M, Cho YB, et al. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia. Int J Radiat Oncol Biol Phys 2007;70:126–133.

    PubMed  Google Scholar 

  18. Lin LL, Yang Z, Mutic S, Miller TR, Grigsby PW. FDG-PET imaging for the assessment of physiologic volume response during radiotherapy in cervix cancer. Int J Radiat Oncol Biol Phys 2006;70:177–181.

    Google Scholar 

  19. Paley PJ, Goff BA, Minudri R, Greer BE, Tamimi HK, Koh WJ. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. Gynecol Oncol 2000:76;373–379.

    Article  PubMed  CAS  Google Scholar 

  20. Azria E, Morice P, Haie-Meder C, Thoury A, Pautier P, Lhomme C, et al. Results of hysterectomy in patients with bulky residual disease at the end of chemoradiotherapy for stage IB2/II cervical carcinoma. Ann Surg Oncol 2005:12;332–337.

    Article  PubMed  Google Scholar 

  21. Eifel PJ, Thoms WW Jr, Smith TL, Morris M, Oswald MJ. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int J Radiat Oncol Biol Phys 1994;28:113–118.

    PubMed  CAS  Google Scholar 

  22. Ohara K, Tanaka YO, Tsunoda H, Oki A, Satoh T, Onishi K, et al. Preliminary estimation of treatment effect on uterine cervical squamous cell carcinoma in terms of tumor regression rate: comparison between chemoradiotherapy and radiotherapy alone. Radiat Med 2005;23:25–29.

    PubMed  Google Scholar 

  23. Mayr NA, Taoka T, Yuh WT, Denning LM, Zhen WK, Paulino AC, et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int J Radiat Oncol Biol Phys 2002;52:14–22.

    PubMed  Google Scholar 

  24. Nag S, Cardenes H, Chang S, Das IJ, Erickson B, Ibbott GS, et al. Proposed guidelines for image-based intracavitary brachytherapy for cervical cancer: report from image-guided brachytherapy working group. Int J Radiat Oncol Biol Phys 2004;60:1160–1172.

    PubMed  Google Scholar 

  25. Haie-Meder C, Pötter R, Van Limbergen E, Briot E, De Brabandere M, Dimopoulos J, et al. Recommendations from Gynaecological (GYN) GEC-ESTRO Working Group (I): concepts and terms in 3D image based 3D treatment planning in cervix cancer brachytherapy with emphasis on MRI assessment of GTV and CTV. Radiother Oncol 2005;74:235–245.

    Article  PubMed  Google Scholar 

  26. Pötter R, Haie-Meder C, van Limbergen E, Barillot I, De Brabandere M, Dimopoulos J, et al. Recommendations from gynaecological (GYN) GEC-ESTRO working group (II): concepts and terms in 3D image-based 3D treatment planning in cervix cancer brachytherapy—3D dose volume parameters and aspect of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 2006;78:67–77.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiyoshi Ohara.

About this article

Cite this article

Ohara, K., Tanaka, Y.O., Oki, A. et al. Comparison of tumor regression rate of uterine cervical squamous cell carcinoma during external beam and intracavitary radiotherapy. Radiat Med 26, 526–532 (2008). https://doi.org/10.1007/s11604-008-0268-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11604-008-0268-1

Key words

Navigation